Precipio customer american oncology network (aon) selected to present hemescreen® technology case study at industry leading clinical laboratory conference

New haven, conn., april 26, 2022 (globe newswire) -- specialty cancer diagnostics company  precipio, inc.   (nasdaq: prpo) , is excited to announce its participation and the presentation of hemescreen, its novel diagnostic technology platform, at the executive war college , organized by publication dark daily, the premier laboratory conference, held april 26th through 28th in new orleans.
PRPO Ratings Summary
PRPO Quant Ranking